VARIXIO

Serial Number 79281626
Registration 6391728
700

Registration Progress

Application Filed
Jan 22, 2020
Under Examination
Approved for Publication
Apr 6, 2021
Published for Opposition
Apr 6, 2021
Registered
Jun 22, 2021

Basic Information

Serial Number
79281626
Registration Number
6391728
Filing Date
January 22, 2020
Registration Date
June 22, 2021
Published for Opposition
April 6, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 22, 2021
Registration
Registered
Classes
010

Rights Holder

Vascular Barcelona Devices, S.L.

99
Address
Oliana 27 Bajos
E-08006 Barcelona
ES

Ownership History

Vascular Barcelona Devices, S.L.

Original Applicant
99
ES

Vascular Barcelona Devices, S.L.

Owner at Publication
99
ES

Vascular Barcelona Devices, S.L.

Original Registrant
99
ES

Legal Representation

Attorney
Justin R. Young

USPTO Deadlines

Next Deadline
714 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-22)
Due Date
June 22, 2027
Grace Period Ends
December 22, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description
Nov 4, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 7, 2021 FIMP P FINAL DISPOSITION PROCESSED
Oct 7, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 6, 2021 PUBO A PUBLISHED FOR OPPOSITION
Apr 6, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2021 GPNX P NOTIFICATION PROCESSED BY IB
Mar 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Feb 16, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Feb 16, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 16, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2021 ALIE A ASSIGNED TO LIE
Oct 20, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 15, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 15, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 15, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 15, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 15, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 15, 2020 RFNT P REFUSAL PROCESSED BY IB
Apr 30, 2020 RFRR P REFUSAL PROCESSED BY MPU
Apr 30, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2020 CNRT R NON-FINAL ACTION WRITTEN
Apr 9, 2020 DOCK D ASSIGNED TO EXAMINER
Apr 3, 2020 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 010
Medical apparatus and instruments for use in endovascular procedures; surgical apparatus and instruments; magnetic treatment apparatus for medical use, namely, magnets for medical purposes; medical apparatus for facilitating the processing of pharmaceutical preparations, namely, medical apparatus for mixing sclerosing agents with gas to generate a foam for sclerotherapy of varicose veins; medical apparatus for introducing pharmaceutical preparations into the human body; apparatus and instruments for treating varicose veins, namely, supportive tapes for varicose veins; medical apparatus and instruments for use in sclerotherapy procedures; instruments for sclerozation, namely, medical instruments for use in sclerotherapy procedures; instruments for intraluminal sclerotherapy of varicose veins, namely, medical instruments for use in sclerotherapy procedures
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the wording "VARIXIO" in a black stylized font with the letter "X" in blue on the left side and purple on the right side with a broken line circle around the "X", the left being in blue and the right in purple.
Color Claim
The color(s) blue, black and purple is/are claimed as a feature of the mark.

Classification

International Classes
010